Cargando…

Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer. It is defined by cholangiocytic differentiation and has poor prognosis. Recently, epigenetic processes have been shown to play an important role in cholangiocarcinogenesis. We performed an integrative analysis on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goeppert, Benjamin, Toth, Reka, Singer, Stephan, Albrecht, Thomas, Lipka, Daniel B., Lutsik, Pavlo, Brocks, David, Baehr, Marion, Muecke, Oliver, Assenov, Yassen, Gu, Lei, Endris, Volker, Stenzinger, Albrecht, Mehrabi, Arianeb, Schirmacher, Peter, Plass, Christoph, Weichenhan, Dieter, Roessler, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594081/ https://www.ncbi.nlm.nih.gov/pubmed/30615206 http://dx.doi.org/10.1002/hep.30493

Ejemplares similares

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
por: Tomczak, Aurelie, et al.
Publicado: (2022)

Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis
por: Goeppert, Benjamin, et al.
Publicado: (2022)

Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer
por: Goeppert, Benjamin, et al.
Publicado: (2015)

Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2019)

Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma
por: Andrici, Juliana, et al.
Publicado: (2016)

Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma
por: Nickkholgh, A., et al.
Publicado: (2019)

The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma
por: Albrecht, Thomas, et al.
Publicado: (2021)

Comprehensive Analysis of DNA Methylation Data with RnBeads
por: Assenov, Yassen, et al.
Publicado: (2014)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

RnBeads 2.0: comprehensive analysis of DNA methylation data
por: Müller, Fabian, et al.
Publicado: (2019)

Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer
por: Albrecht, Thomas, et al.
Publicado: (2021)

Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
por: Tóth, Marcell, et al.
Publicado: (2021)

Club cells employ regeneration mechanisms during lung tumorigenesis
por: Chen, Yuanyuan, et al.
Publicado: (2022)

First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma
por: Neumann, Olaf, et al.
Publicado: (2023)

Epigenetic reprogramming of airway macrophages promotes polarization and inflammation in muco-obstructive lung disease
por: Hey, Joschka, et al.
Publicado: (2021)

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies
por: Kriegsmann, Mark, et al.
Publicado: (2019)

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2018)

Enrichment analysis with EpiAnnotator
por: Pageaud, Yoann, et al.
Publicado: (2018)

Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis
por: Charbel, Alphonse, et al.
Publicado: (2022)

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
por: Neumann, Olaf, et al.
Publicado: (2022)

STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma
por: Ploeger, Carolin, et al.
Publicado: (2022)

PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
por: Kelekci, Simge, et al.
Publicado: (2023)

N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas
por: Gerber, Tiemo S., et al.
Publicado: (2022)

Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
por: Lin, Jian, et al.
Publicado: (2022)

Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL
por: Wierzbinska, Justyna A., et al.
Publicado: (2020)

P440: ENHANCER HIJACKING IN COMPLEX-KARYOTYPE AML
por: Sollier, Etienne, et al.
Publicado: (2023)

Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p
por: Goeppert, Benjamin, et al.
Publicado: (2019)

IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
por: Xiang, Xiao, et al.
Publicado: (2021)

Low frequency of mismatch repair deficiency in gallbladder cancer
por: Goeppert, Benjamin, et al.
Publicado: (2019)

Neuronal ensemble-specific DNA methylation strengthens engram stability
por: Gulmez Karaca, Kubra, et al.
Publicado: (2020)

Maftools: efficient and comprehensive analysis of somatic variants in cancer
por: Mayakonda, Anand, et al.
Publicado: (2018)

DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours
por: Dragomir, Mihnea P., et al.
Publicado: (2023)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis
por: Souren, Nicole Y., et al.
Publicado: (2019)

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
por: Albrecht, Thomas, et al.
Publicado: (2019)

Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability
por: Jäkel, Cornelia, et al.
Publicado: (2017)

Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
por: Budczies, Jan, et al.
Publicado: (2017)

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences
por: Kriegsmann, Mark, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_so3gs9slratk44ree2gffvdotj